openPR Logo
Press release

Epigenetics Market | Size | Share | Global Industry Report 2018 - 2024

02-08-2019 11:43 AM CET | Health & Medicine

Press release from: Precision Business Insights

epigenetics

epigenetics

A Global Report On Epigenetics Market With Analysis And Past, Present And Future Trends

Epigenetics are emerged as to include any process that alters gene activity without changing the DNA sequence. It is basically a study of heritable changes in gene expression which involves the change in phenotype without changing genotype. Epigenetic changes are affected by various factors like lifestyle, environment, age and state of disease. Epigenetic modifications can manifest a common manner of cells which differentiate terminally to end up as liver cells, skin cells, brain cells etc. Epigenetic change may have more damaging effects which can lead to diseases like cancer.

Request Sample Report : https://precisionbusinessinsights.com/request-sample?product_id=17020

The surge in the prevalence of cancer, improving funds and aids for the R&D activities, rise in the partnerships between pharmaceutical and biotechnology companies and research institutes, increase in epigenetics application in non-oncology diseases will propel the epigenetics drug market. Moreover, improved advancements in epigenetics technology, untapped potential of emerging markets like India and China are expected to offer many opportunities for the growth of epigenetics research market. However, high instrument cost and the paucity of skilled personnel are expected to hamper the growth of the epigenetics drug market.
The global Epigenetics market is classified on the basis of following categories-
1. Enzymes
• DNA polymerase
• Acetylases
• DNA ligases
• Methyltransferase
• RNA ligases
• Reverse Transcriptase
• Others
2. Instruments
• Next generation sequencers
• Mass spectrometers
• Sonicators
• qPCRs
• Others
3. Applications
• Oncology
• Cardiovascular diseases
• Metabolic diseases
• Inflammatory diseases
• Infectious diseases
4. Kits and assays
• Deep sequencing kit
• Bisulfate conversion kit
• Methyltransferase assays
• Chip- sequence kits
• Immunoprecipitation kits
• Histone assay
5. End-users
Pharmaceutical and biotechnological companies, Contract research companies and Academic and Research Institutes.
And lastly, on the basis of geographical regions, the global Epigenetics market have five major regions- Latin America, Europe, Asia- Pacific, North America, and the Middle East & Africa. North America holds the largest share in epigenetics drug market due to rise in prevalence of cancer, high funding on R&D, increasing acquisitions and collaborations among large pharma companies, high adaptation and awareness of new technologies and healthcare infrastructure. Asia Pacific is a lucrative market owing to the presence of favorable regulatory framework, high incidence and prevalence of diabetes, cancer and cardiovascular diseases among the population of Asia Pacific countries. Some of the key players in epigenetics research market Illumina, Inc. (U.S.), Abcam plc. (U.K), QIAGEN N.V. (Netherland), New England Biolabs, Inc. (U.S.), Merck & Co. (U.S.), Sigma-Aldrich Corporation (U.S.), Genedata AG(Switzerland), Active Motif (U.S.), Thermo Fisher Scientific, Inc., (U.S.), Diagenode, Inc. (Belgium), and Episona Inc. (U.S).In 2016, an epigenetics data company launched SEED a novel male fertility test to evaluate epigenetic changes on DNA to detect a risk of infertility and poor embryo development.
Epigenetics has triggered R&D for new drugs for various cancers, chronic and autoimmune disorders. Introduction of advanced technologies and potential investments on R&D activities are expected to fuel the growth of epigenetics. The epigenetics market report shows that companies are focusing on detection of DNA methylation patterns and histone modification. Development of high specific antibodies for accurate and rapid detection of modifications of histone core proteins.

For More Information : https://precisionbusinessinsights.com/market-reports/global-epigenetics-market/

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and

customized market research services based on our client needs.

Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Epigenetics Market | Size | Share | Global Industry Report 2018 - 2024 here

News-ID: 1572346 • Views: 182

More Releases from Precision Business Insights

Clinical Trials Market Share, Trends, Competitor Analysis and Forecast to 2019-2 …
Analyst Speak: “The Global Clinical Trials Market is expected to reach US$ 69.1 Bn by 2025 due to growing occurrences of life threatening diseases and technological advancements in the field of drug discovery” The global clinical trials market is expected to reach US$ 69.1 Bn by 2025. Clinical trials are experiments or observations done in clinical research to generate data on safety and efficacy. Clinical trials are done on vaccines, drugs,
Diabetes Care Devices Market is Expected to Reach US$ 24,368.4 Mn by 2025
Analyst Speak: “The Diabetes Care Devices Market is increasing at significant CAGR over the forecast period 2019-2025 and expected to reach US$ 24,368.4 Mn by 2025, due to rise in prevalence of diabetes in various countries around the world”. Precision Business Insights (PBI) in its report titled “Diabetes Care Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period
Carbon Fiber Prepreg Market Opportunities, Size, Share, Key Players, and Regiona …
The Global Carbon Fiber Prepreg Market poised to reach US$ XX Mn by 2025 with a significant CAGR over seven years forecast period 2019-2025 owing to the increasing demand from various industries. Precision Business Insights (PBI) in its report titled “Global Carbon Fiber Prepreg Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025.
Global Insulation Coatings Market Growth, Trends, Analysis, Segmentation, Foreca …
Precision Business Insights (PBI) in its report titled “Global Insulation Coating Material Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Global Insulation Coating Material Market

All 5 Releases


More Releases for Epigenetic

Epigenetic Market Forecast By End-use Industry 2016-2026
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,
Epigenetic Market Growth with Worldwide Industry Analysis to 2026
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,
Epigenetic Market to Register Steady Growth During 2016 - 2026
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,
Innovations will Boost Epigenetic Market Growth in the Foreseeable Future
The epigenetic process includes phosphorylation, methylation, sumolyation, acetylation and ubiquitylation etc. of DNA as well as histones resulting in changes in Phenotypes. These changes are modified with environmental conditions. Epigenetic market is now an emerging field. There are various diagnostic tests available now that detect epigenetic changes. There are some FDA approved epigenetic drugs. Other than many diagnostic companies, many biopharmaceutical and pharmaceutical companies are also very active in the
Epigenetic Market Rugged Expansion Foreseen by 2026
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,
Epigenetic Market Plying for Significant Growth During 2016-2026
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,